CLL-like monoclonal B-cell lymphocytosis: Are we all bound to have it?

Seminars in Cancer Biology

Volumn 20, Issue 6, 2010, Pages 384-390

  Scarfò, Lydia ^a,b   Dagklis, Antonis ^a   Scielzo, Cristina ^a,c   Fazi, Claudia ^a   Ghia, Paolo ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Chronic lymphocytic leukemia; Immunosenescence; Monoclonal B cell lymphocytosis

Indexed keywords

AGE; AGING; B CELL LYMPHOCYTOSIS; B LYMPHOCYTE; CANCER RESEARCH; CANCER RISK; CELL EXPANSION; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; DISEASE MODEL; FLOW CYTOMETRY; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; LEUKEMOGENESIS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOSIS; MORBIDITY; NONHUMAN; PRELEUKEMIA; REVIEW; RISK ASSESSMENT;

AGE DISTRIBUTION; ANIMALS; B-LYMPHOCYTES; CELL AGING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS;

EID: 78649784110     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2010.08.005     Document Type: Review

References (76)

1. Han T., Ozer H., Gavigan M., Gajera R., Minowada J., Bloom M.L., et al. Benign monoclonal B cell lymphocytosis-a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood 1984, 64(1):244-252.
2. Marti G.E., Rawstron A.C., Ghia P., Hillmen P., Houlston R.S., Kay N., et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005, 130(3):325-332.
3. Caligaris-Cappio F., Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?. J Clin Oncol 2008, 26(27):4497-4503.
4. Ghia P., Ferreri A.M., Caligaris-Cappio F. Chronic lymphocytic leukemia. Crit Rev Oncol Hematol 2007, 64(3):234-246.
5. Ghia P., Prato G., Scielzo C., Stella S., Geuna M., Guida G., et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004, 103(6):2337-2342.
6. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Dohner H., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008, 111(12):5446-5456.
7. Marti G., Abbasi F., Raveche E., Rawstron A.C., Ghia P., Aurran T., et al. Overview of monoclonal B-cell lymphocytosis. Br J Haematol 2007, 139(5):701-708.
8. Shanafelt T.D., Ghia P., Lanasa M.C., Landgren O., Rawstron A.C. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010, 24(3):512-520.
9. Kyle R.A., Therneau T.M., Rajkumar S.V., Larson D.R., Plevak M.F., Offord J.R., et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006, 354(13):1362-1369.
10. Caligaris-Cappio F., Gobbi M., Bofill M., Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 1982, 155(2):623-628.
11. Klein U., Tu Y., Stolovitzky G.A., Mattioli M., Cattoretti G., Husson H., et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001, 194(11):1625-1638.
12. Damle R.N., Ghiotto F., Valetto A., Albesiano E., Fais F., Yan X.J., et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002, 99(11):4087-4093.
13. Vogt R.F., Shim Y.K., Middleton D.C., Buffler P.A., Campolucci S.S., Lybarger J.A., et al. Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br J Haematol 2007, 139(5):690-700.
14. Shim Y.K., Vogt R.F., Middleton D., Abbasi F., Slade B., Lee K.Y., et al. Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom 2007, 72(5):344-353.
15. Plapp F.V., Rachel J.M., Zucker M.L. Chronic B lymphocytic leukemia in blood donors. Transfusion 1999, 39.
16. Rachel J.M., Zucker M.L., Fox C.M., Plapp F.V., Menitove J.E., Abbasi F., et al. Monoclonal B-cell lymphocytosis in blood donors. Br J Haematol 2007, 139(5):832-836.
17. Rawstron A.C., Green M.J., Kuzmicki A., Kennedy B., Fenton J.A., Evans P.A., et al. Monoclonal B lymphocytes with the characteristics of " indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002, 100(2):635-639.
18. Dagklis A., Fazi C., Sala C., Cantarelli V., Scielzo C., Massacane R., et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood 2009, 114(1):26-32.
19. Nieto W.G., Almeida J., Romero A., Teodosio C., Lopez A., Henriques A.F., et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009, 114(1):33-37.
20. Landgren O., Albitar M., Ma W., Abbasi F., Hayes R.B., Ghia P., et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009, 360(7):659-667.
21. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94(6):1840-1847.
22. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94(6):1848-1854.
23. Rawstron A.C., Bennett F., Hillmen P. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia. Br J Haematol 2007, 139(5):724-729.
24. Neuland C.Y., Blattner W.A., Mann D.L., Fraser M.C., Tsai S., Strong D.M. Familial chronic lymphocytic leukemia. J Natl Cancer Inst 1983, 71(6):1143-1150.
25. Bevan S., Catovsky D., Matutes E., Antunovic P., Auger M.J., Ben-Bassat I., et al. Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. Blood 2000, 96(12):3982-3984.
26. Goldin L.R., Bjorkholm M., Kristinsson S.Y., Turesson I., Landgren O. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica 2009, 94(5):647-653.
27. Gunz F.W., Gunz J.P., Veale A.M., Chapman C.J., Houston I.B. Familial leukaemia: a study of 909 families. Scand J Haematol 1975, 15(2):117-131.
28. Linet M.S., Van Natta M.L., Brookmeyer R., Khoury M.J., McCaffrey L.D., Humphrey R.L., et al. Familial cancer history and chronic lymphocytic leukemia. A case-control study. Am J Epidemiol 1989, 130(4):655-664.
29. Capalbo S., Trerotoli P., Ciancio A., Battista C., Serio G., Liso V. Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage. Eur J Haematol 2000, 65(2):114-117.
30. Marti G.E., Carter P., Abbasi F., Washington G.C., Jain N., Zenger V.E., et al. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom 2003, 52(1):1-12.
31. Rawstron A.C., Yuille M.R., Fuller J., Cullen M., Kennedy B., Richards S.J., et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 2002, 100(7):2289-2290.
32. de Tute R., Yuille M., Catovsky D., Houlston R.S., Hillmen P., Rawstron A.C. Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults. Leukemia 2006, 20(4):728-729.
33. Goldin L., Lanasa M.C., Slager S.L., Strom S.S., Camp N.J., Cerhan J.R., Leis J.F., Rassenti L.Z., Fontaine L., Abbasi F., Call T.G., Weinberg J.B., Caporaso N.E., et al. Monoclonal B-cell lymphocytosis is commonly observed among unaffected members of high risk CLL families. Blood 2009, 114(22).
34. Mulligan C.S., Thomas M.E., Mulligan S.P. Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL). Blood 2009, 113(25):6496-6497. author reply 6497-8.
35. Shanafelt T.D., Kay N.E., Jenkins G., Call T.G., Zent C.S., Jelinek D.F., et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009, 113(18):4188-4196.
36. Shanafelt T.D., Kay N.E., Call T.G., Zent C.S., Jelinek D.F., LaPlant B., et al. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥5×10(9)L(-1) but a B-cell lymphocyte count <5×10(9)L(-1)?. Leuk Res 2008, 32(9):1458-1461.
37. Mulligan C.S., Thomas M.E., Mulligan S.P. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008, 359(19):2065-2066. author reply 2066.
38. Fung S.S., Hillier K.L., Leger C.S., Sandhu I., Vickars L.M., Galbraith P.F., et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk Lymphoma 2007, 48(6):1087-1091.
39. Shanafelt T.D., Kay N.E., Rabe K.G., Call T.G., Zent C.S., Maddocks K., et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009, 27(24):3959-3963.
40. Rawstron A.C., Bennett F.L., O'Connor S.J., Kwok M., Fenton J.A., Plummer M., et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008, 359(6):575-583.
41. Rossi D., Sozzi E., Puma A., De Paoli L., Rasi S., Spina V., et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009, 146(1):64-75.
42. Rawstron A.C., Shanafelt T., Lanasa M.C., Landgren O., Hanson C., Orfao A., et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010, 78B(Suppl. 1):S19-S23.
43. Dores G.M., Anderson W.F., Curtis R.E., Landgren O., Ostroumova E., Bluhm E.C., et al. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 2007, 139(5):809-819.
44. Bennett F., Dalal S., Jack A.S., Hillmen P., Rawstron A.C. Five-year follow-up of monoclonal B-Cell lymphocytosis (MBL) in individuals with a normal blood count: expansion of the abnormal B-Cell compartment but no progressive disease. Blood 2009, 114(22).
45. Ghia P., Fazi C., Pecciarini L., Scarfò L., Cottini F., Dagklis A., et al. CLL-Like MBL in the general population persist over time, without clinical progression, though carrying the same cytogenetic abnormalities of CLL. Blood 2010, 116.(22).
46. Dagklis A., Fazi C., Scarfo L., Apollonio B., Ghia P. Monoclonal B lymphocytosis in the general population. Leuk Lymphoma 2009, 50(3):490-492.
47. Almeida J., Nieto W., Teodosio C., Pedreira C., Nieto A., Romero A., Rodríguez-Caballero A., Rasillo A., Vega T., et al. Small CLL-like B-cell clones in healthy adult subjects: leukemic precursors versus counterpart of CLL cells?. Haematologica 2010, 95(Suppl. 2):317.
48. Bichi R., Shinton S.A., Martin E.S., Koval A., Calin G.A., Cesari R., et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002, 99(10):6955-6960.
49. Yan X.J., Albesiano E., Zanesi N., Yancopoulos S., Sawyer A., Romano E., et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2006, 103(31):11713-11718.
50. Klein U., Lia M., Crespo M., Siegel R., Shen Q., Mo T., et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010, 17(1):28-40.
51. Phillips J.A., Mehta K., Fernandez C., Raveche E.S. The NZB mouse as a model for chronic lymphocytic leukemia. Cancer Res 1992, 52(2):437-443.
52. Hamano Y., Hirose S., Ida A., Abe M., Zhang D., Kodera S., et al. Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice. Blood 1998, 92(10):3772-3779.
53. Stall A.M., Farinas M.C., Tarlinton D.M., Lalor P.A., Herzenberg L.A., Strober S., et al. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc Natl Acad Sci USA 1988, 85(19):7312-7316.
54. LeMaoult J., Manavalan J.S., Dyall R., Szabo P., Nikolic-Zugic J., Weksler M.E. Cellular basis of B cell clonal populations in old mice. J Immunol 1999, 162(11):6384-63891.
55. Seldin M.F., Conroy J., Steinberg A.D., D'Hoosteleare L.A., Raveche E.S. Clonal expansion of abnormal B cells in old NZB mice. J Exp Med 1987, 166(5):1585-1590.
56. Wick G., Grubeck-Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 1997, 32(4-5):401-413.
57. Ben-Yehuda A., Weksler M.E. Host resistance and the immune system. Clin Geriatr Med 1992, 8(4):701-711.
58. Klinman N.R., Kline G.H. The B-cell biology of aging. Immunol Rev 1997, 160:103-114.
59. LeMaoult J., Szabo P., Weksler M.E. Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev 1997, 160:115-126.
60. Ghia P., Melchers F., Rolink A.G. Age-dependent changes in B lymphocyte development in man and mouse. Exp Gerontol 2000, 35(2):159-165.
61. Nicoletti C. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen. Exp Mol Pathol 1995, 62(2):99-108.
62. Szabo P., Zhao K., Kirman I., Le Maoult J., Dyall R., Cruikshank W., et al. Maturation of B cell precursors is impaired in thymic-deprived nude and old mice. J Immunol 1998, 161(5):2248-2253.
63. Lanasa M.C., Allgood S.D., Volkheimer A.D., Gockerman J.P., Whitesides J.F., Goodman B.K., et al. Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis. Leukemia 2010, 24(1):133-140.
64. Lanasa M.C., Allgood S.D., Weinberg J.B. Monoclonal B cell lymphocytosis. Leuk Lymphoma 2010, 51(8):1386-1388.
65. Colombatti A., Doliana R., Schiappacassi M., Argentini C., Tonutti E., Feruglio C., et al. Age-related persistent clonal expansions of CD28(-) cells: phenotypic and molecular TCR analysis reveals both CD4(+) and CD4(+)CD8(+) cells with identical CDR3 sequences. Clin Immunol Immunopathol 1998, 89(1):61-70.
66. Ghia P., Prato G., Stella S., Scielzo C., Geuna M., Caligaris-Cappio F. Age-dependent accumulation of monoclonal CD4+CD8+ double positive T lymphocytes in the peripheral blood of the elderly. Br J Haematol 2007, 139(5):780-790.
67. Khan N., Shariff N., Cobbold M., Bruton R., Ainsworth J.A., Sinclair A.J., et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002, 169(4):1984-1992.
68. Fazi C., Dagklis A., Cottini F., Scarfò L., Bertilaccio M.T.S., Finazzi R., et al. Monoclonal B cell lymphocytosis in HCV-infected individuals. Cytometry B Clin Cytom; 2010, 78B(Suppl. 1):S61-S68.
69. Ghia P., Chiorazzi N., Stamatopoulos K. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 2008, 264(6):549-562.
70. Chiorazzi N., Hatzi K., Albesiano E. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann N Y Acad Sci 2005, 1062:1-12.
71. Landgren O., Rapkin J.S., Caporaso N.E., Mellemkjaer L., Gridley G., Goldin L.R., et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007, 109(5):2198-2201.
72. Williams A.R., Balasooriya B.A., Day D.W. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982, 23(10):835-842.
73. Vatn M.H., Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982, 49(4):819-825.
74. Jass J.R., Young P.J., Robinson E.M. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 1992, 33(11):1508-1514.
75. Gronberg H. Prostate cancer epidemiology. Lancet 2003, 361(9360):859-864.
76. Honn K.V., Aref A., Chen Y.Q., Cher M.L., Crissman J.D., Forman J.D., et al. Prostate cancer old problems and new approaches: Part I. epidemiology, incidence and genetic alterations. Pathol Oncol Res 1996, 2(1-2):98-109.